a2596b69-9ece-5cbc-9236-e60fac2cba79
at
ClaimsKG
http://data.gesis.org/claimskg/creative_work/a2596b69-9ece-5cbc-9236-e60fac2cba79
Property
Value
?:
citation
<
https://archive.is/DFDvz?
>
<
https://link.springer.com/article/10.2165/00002018-200326020-00004?
>
<
https://snopes.com/fact-check/rating/true?
>
<
https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm126085.htm?
>
<
https://www.fda.gov/Drugs/DrugSafety/ucm511530.htm?
>
<
https://www.fda.gov/downloads/Drugs/DrugSafety/UCM246794.pdf?
>
<
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502655?
>
<
https://www.ncbi.nlm.nih.gov/pubmed/10064255?dopt%3DAbstract
>
<
https://www.ncbi.nlm.nih.gov/pubmed/26393387?
>
is
?:
itemReviewed
of
claimskg:
claim_review/41a3af47-16de-58d6-aad7-920eaaa2a9cf
?:
keywords
claimskg:
keyword/bf9c19d3-39ab-5bec-b625-dc56be2cc1e5
?:
mentions
claimskg:
mention/c9f25fd7-10b9-59c7-9202-2b454f405c19
claimskg:
mention/cacc90c8-6598-547c-98d2-89be05f821e5
?:
text
The FDA has updated its warnings for — and recommended limitations on — prescribing a class of antibiotics called fluoroquinolones, citing potentially irreversible side-effects including tendon damage and rupture.
(en)
rdf:
type
<
http://schema.org/CreativeWork
>